SER (Serina Therapeutics) Other Current Liabilities: $2.88 Mil (As of Mar. 2026)


SER Serina Therapeutics Inc SER
12 GF Score
Price $1.94
! 1 Warning Sign
View Full Analysis

What is Serina Therapeutics Other Current Liabilities?

Serina Therapeutics SER -1.52% 12 Other Current Liabilities is $2.88 Mil as of Mar. 2026. GuruFocus rates SER with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Serina Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was $2.88 Mil.

Serina Therapeutics's quarterly other current liabilities declined from Sep. 2025 ($2.65 Mil) to Dec. 2025 ($1.24 Mil) but then increased from Dec. 2025 ($1.24 Mil) to Mar. 2026 ($2.88 Mil).

Serina Therapeutics's annual other current liabilities increased from Dec. 2023 ($0.25 Mil) to Dec. 2024 ($1.06 Mil) and increased from Dec. 2024 ($1.06 Mil) to Dec. 2025 ($1.24 Mil).

Serina Therapeutics Other Current Liabilities Related Terms

Serina Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Serina Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Serina Therapeutics Other Current Liabilities Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
-0.00 -0.00 0.25 1.06 1.24

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 1.07 2.65 1.24 2.88
SER
12GF Score
Serina Therapeutics Inc SER
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Serina Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $2.88 Mil mean?
Serina Therapeutics (SER) has a Other Current Liabilities of $2.88 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Serina Therapeutics.
Is Serina Therapeutics' Other Current Liabilities too high?
Serina Therapeutics' current Other Current Liabilities is $2.88 Mil. Overall, Serina Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Serina Therapeutics' Other Current Liabilities compare to NRSN and IGC?
Serina Therapeutics' Other Current Liabilities of $2.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Serina Therapeutics. Serina Therapeutics's current Other Current Liabilities is $2.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Serina Therapeutics stock overvalued right now?
Serina Therapeutics (SER) has a current Other Current Liabilities of $2.88 Mil. The current Other Current Liabilities is $2.88 Mil. Serina Therapeutics' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Serina Therapeutics (SER), the current Other Current Liabilities is $2.88 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Serina Therapeutics Business Description

Other Exchanges 2BO:Germany
Address 601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
12GF Score

Get the complete analysis for SER

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.94
Price